{"version":"1.0","type":"link","title":"Osimertinib acquired resistance among patients with EGFR-mutated NSCLC: from molecular mechanisms to clinical therapeutic strategies.","author_name":"Wang R 외","author_url":"https://prs-insight.online/author/Wang%20R","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/100573","thumbnail_width":1200,"thumbnail_height":630}